Italy to increase tobacco prices in 2023

Dec.27.2022
Italian tobacco products will face a price hike in 2023 due to tax changes, affecting cigarette and e-cigarette users.

Smokers in Italy received some bad news as tobacco products will experience a price hike in 2023. The reason for this is due to a revision included in the 2023 budget law, which aims to reshuffle consumption taxes between different products through changes in taxes.

 

As we mentioned earlier, tobacco product users can expect to see a hike in the prices of their vice in 2023. According to the latest developments, a provision increasing the specific consumption tax on cigarettes has been approved by the executive branch led by President Meloni in the 2023 Budget Act. Starting January 1st, 2023, each pack of cigarettes will see a price increase of €0.20 (approximately RMB 1.48), with varying degrees of increment depending on the brand.

 

But that's not all. In 2024, the increase in cigarette prices will continue, with an additional raise of 0.10 or 0.15 euros after the growth in 2023. In other words, starting in 2024, cigarettes may cost an extra 35 cents (about 2.24 yuan) per pack.

 

In 2023, the growth is not only targeted at cigarette users, but also affects those who use electronic cigarettes, such as heated tobacco. However, for this type of cigarette, the increase in price is relatively small, with non-nicotine cigarettes costing approximately 0.08 euros per milliliter (about 0.59 yuan), while nicotine-containing cigarettes will rise to 0.13 euros (about 0.96 yuan).

 

The government's recent estimate projects that Italy could collect at least 100 million euros annually as the price of cigarettes and tobacco is set to increase by 2023.

 

It has been announced that cigarettes and tobacco will increase in price in 2023, but what will their prices be in 2021, with the introduction of the euro? The official website of the State Monopoly Agency for Customs and Excise has released a list of cigarette prices, including all brands available to the public, updated as of November 24th of this year. We can see that in 2022, a pack of cigarettes will cost between 4.8 and 6 euros.

 

Considering the rise in cigarette and tobacco prices in 2023, lower-priced cigarette packs may need to cost 5 euros, while higher-priced packs could even cost 6.20 euros. But what were cigarette prices in 2001? At that time, MS cost 2.17 euros, Camel increased to 2.48 euros, and the most popular brand, Marlboro, was priced at 3 euros. In short, over the last 20 years, cigarette prices have increased by more than 2 euros.

 

Let's take a look at who will spend more money next year in Italy, as cigarettes and tobacco prices are set to increase in 2023.

 

According to data analysis from Epicentre ISS, we can estimate that Italian regions will spend more money on cigarette and tobacco packaging next year due to the Meloni government's plan to increase prices in 2023, based on a two-year period from 2020-2021.

 

In Italy, where do people smoke the most? Among the regions with the highest smoking rates, the top ranking is held by certain areas in central and southern Italy, particularly Abruzzo, Umbria, and Campania, but there are also significant numbers of smokers in Emilia-Romagna.

 

On the contrary, in 2023, the regions of Puglia, Marche, Calabria and Friuli-Venezia Giulia will be less affected by the increase in cigarette and tobacco prices.

 

Data from the Istituto Superiore di Sanità reveals that in Italy, 50% of the population does not smoke, while 24.5% have a habitual consumption of cigarettes.

 

With the awareness that cigarettes and tobacco will increase in price in 2023, let's take a look at how much revenue the country generates from cigarette sales. In this scenario, data from 2020 from the demographic analysis institution, Eurispes, reveal that the country collects approximately 14 billion euros yearly from cigarette sales.

 

However, it is important to note that if we consider the expenses borne by the country itself on an annual basis to support public health measures, prevent and treat diseases related to tobacco consumption, the net profit is actually half of this figure, approximately 7 billion euros.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Vaping brand OXVA introduced the XLIM PRO 4 refillable pod system in October 2026, featuring Anti-Burn Tech (ABT) based on smart e-liquid-level detection. The system can issue refill alerts and stop power output when e-liquid levels become too low. ABT requires the XLIM PRO 4 device and a dedicated XLIM ABT cartridge. Standard XLIM pods remain compatible but do not support ABT protection. OXVA previously introduced temperature-based anti-burn technology in the XLIM Pro 2 DNA, developed with Evolv. The new device features a 1,800mAh battery, 5–30W output and a 0.98-inch HD color screen. OXVA's official store lists the device at $37.90 and dedicated ABT replacement cartridges at $12.99. Independent testing confirmed the low-liquid protection response but recorded varying cartridge lifespans.
product
Oct.30